Skip to content

600866.SH

星湖科技

SSE · Healthcare · Biotechnology · CN

CNY 4.23
−0.47%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue15.6B15.9B17.3B17.4B17.5B
Cost of Revenue13.6B13.3B14.4B14.9B14.4B
Gross Profit2.0B2.6B3.0B2.4B3.1B
Operating Expenses
R&D Expense178.7M184.1M171.9M181.6M182.6M
SG&A Expense
General & Admin Expense803.8M755.2M718.6M640.5M681.2M
Selling & Marketing Expense317.9M319.3M366.0M321.1M266.4M
Other Expenses
Total Operating Expenses1.5B1.4B1.4B1.4B1.6B
Cost and Expenses15.0B14.7B15.8B16.3B16.0B
Operating Income (EBIT)541.9M1.2B1.2B867.4M1.4B
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)574.0M1.2B1.2B863.6M1.4B
Income Tax Expense124.8M248.2M283.3M177.9M240.6M
Bottom Line
Net Income457.8M978.9M943.2M678.0M608.3M
Earnings from Cont. Ops449.2M970.0M949.8M685.7M1.2B
Earnings from Discont. Ops
Bottom Line Net Income457.8M978.9M943.2M678.0M608.3M
Per Share
Basic EPSCN¥0.28CN¥0.59CN¥0.57CN¥0.41CN¥0.51
Diluted EPSCN¥0.28CN¥0.59CN¥0.57CN¥0.41CN¥0.51
Revenue Per ShareCN¥9.38CN¥9.57CN¥10.43CN¥10.46CN¥14.72
Shares
Basic Shares Outstanding1.7B1.7B1.7B1.7B1.2B
Diluted Shares Outstanding1.7B1.7B1.7B1.7B1.2B
Profitability Metrics
EBITDA2.0B2.1B1.7B2.4B
D&A842.0M840.1M852.1M980.5M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026